US Patent Application No: 2002/0045,609

Number of patents in Portfolio can not be more than 2000

Epothilone derivatives and methods for making and using the same

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to 16-membered macrocyclic compounds. These compounds are cytotoxic agents and can be used to treat cancer and non-cancer disorders characterized by cellular hyperproliferation.

Loading the Abstract Image... loading....

First Claim

See full text

all claims..

Related Publications

Loading Related Publications... loading....

Patent Owner(s)

Patent OwnerAddressTotal Patents
KOSAN BIOSCIENCES, INC.HAYWARD, CA118

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Ashley, Gary Alameda, CA 68 282
Fardis, Maria San Carlos, CA 64 169
Santi, Daniel San Francisco, CA 37 170

Patent Citation Ranking

Forward Cite Landscape

Patent Info (Count) # Cites Year
 
SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH (15)
6,849,651 Synthesis of epothilones, intermediates thereto, analogues and uses thereof 0 2001
6,972,335 Synthesis of epothilones, intermediates thereto, analogues and uses thereof 1 2001
6,828,340 Synthesis of epothilones, intermediates thereto, analogues and uses thereof 2 2002
6,603,023 Synthesis of epothilones, intermediates thereto and analogues thereof 10 2002
6,965,034 Synthesis of epothilones, intermediates thereto and analogues thereof 0 2002
6,723,854 Synthesis of epothilones, intermediates thereto, analogues and uses thereof 10 2003
6,921,769 Synthesis of epothilones, intermediates thereto and analogues thereof 7 2003
7,649,006 Synthesis of epothilones, intermediates thereto and analogues thereof 0 2003
7,759,374 Synthesis of epothilones, intermediates thereto and analogues thereof 0 2006
RE41990 Synthesis of epothilones, intermediates thereto, analogues and uses thereof 1 2007
7,750,164 Synthesis of epothilones, intermediates thereto, analogues and uses thereof 1 2007
7,875,638 Synthesis of epothilones, intermediates thereto, analogues and uses thereof 0 2008
8,110,590 Synthesis of epothilones, intermediates thereto and analogues thereof 0 2009
8,481,575 Synthesis of epothilones, intermediates thereto, analogues and uses thereof 0 2011
8,513,429 Synthesis of epothilones, intermediates thereto and analogues thereof 0 2012
 
BRISTOL-MYERS SQUIBB COMPANY (3)
7,022,330 Parenteral formulation for epothilone analogs 6 2002
6,670,384 Methods of administering epothilone analogs for the treatment of cancer 32 2002
8,632,788 Parenteral formulation for epothilone analogs 0 2008
 
BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (2)
7,129,254 Effector conjugates, process for their production and their pharmaceutical use 1 2003
7,335,775 Effector conjugates, process for their production and their pharmaceutical use 1 2006
 
UNIVERSITY OF SOUTHERN CALIFORNIA (2)
8,008,256 Combination therapy for treatment of cancer 1 2007
8,685,668 Method of expressing proteins with disulfide bridges 0 2012
 
KOSAN BIOSCIENCES, INC. (1)
7,459,294 Method of producing a compound by fermentation 0 2004
 
Other [Check patent profile for assignment information] (1)
8,802,394 Method of expressing proteins with disulfide bridges with enhanced yields and activity 0 2009